FinAd research workflow
finad.shardingsmeet.com
Research mode active. Personalized investment actions require suitability and advisor approval.

FinAd is in research and education mode by default. Outputs are probabilistic research signals, not guaranteed returns or personalized investment advice.

Personalized investment recommendations for Indian securities must be reviewed and approved by a SEBI-registered investment adviser or authorized expert workflow before being shown as advice.

NSE:AUROPHARMA

Aurobindo Pharma

Healthcare / Healthcare. Analysis combines daily candles, derived indicators, fundamentals, news intelligence, and review-gated recommendations.

quality
62
momentum
91
valuation
32
news
50
liquidity
70
risk
52

Recommendations by horizon

NSE:AUROPHARMA / 20D

Aurobindo Pharma

momentum-trend
ACCUMULATEResearch mode
Confidence70/100
Risk52/100
Why this is ranked here
  • Trend score is supported by moving-average alignment and relative strength.
  • No promoter pledge is present in the sample fundamental snapshot.
What can go wrong
  • Momentum may be extended; entry timing requires discipline.
  • All signals are probabilistic and require SEBI-registered advisor review before personalized advice.
Entry: 1126.76 - 1155.34 around confirmed liquidity
Invalidation: 924.58
Freshness: 2026-05-07
Model: finad-explainable-v0.1.0
NSE:AUROPHARMA / 6M

Aurobindo Pharma

balanced-ai-blend
HOLDResearch mode
Confidence58/100
Risk52/100
Why this is ranked here
  • Trend score is supported by moving-average alignment and relative strength.
  • No promoter pledge is present in the sample fundamental snapshot.
What can go wrong
  • Momentum may be extended; entry timing requires discipline.
  • All signals are probabilistic and require SEBI-registered advisor review before personalized advice.
Entry: 1116.37 - 1155.34 around confirmed liquidity
Invalidation: 924.58
Freshness: 2026-05-07
Model: finad-explainable-v0.1.0
NSE:AUROPHARMA / MULTI_YEAR

Aurobindo Pharma

quality-compounder
HOLDResearch mode
Confidence57/100
Risk52/100
Why this is ranked here
  • Trend score is supported by moving-average alignment and relative strength.
  • No promoter pledge is present in the sample fundamental snapshot.
What can go wrong
  • Momentum may be extended; entry timing requires discipline.
  • All signals are probabilistic and require SEBI-registered advisor review before personalized advice.
Entry: 1116.37 - 1155.34 around confirmed liquidity
Invalidation: 924.58
Freshness: 2026-05-07
Model: finad-explainable-v0.1.0